(XDJP) Xtrackers Nikkei 225 1D - Ratings and Ratios
Equities, Japan, Index, Replication, Liquidity
Description: XDJP Xtrackers Nikkei 225 1D September 24, 2025
The Xtrackers Nikkei 225 UCITS ETF 1D (XETRA: XDJP) seeks to track the Morningstar Japan TME NR JPY index, which mirrors the performance of the 225 most liquid stocks on the Tokyo Stock Exchange First Section. The fund replicates the index by holding the constituent shares in the same weightings, with periodic rebalancing based on five-year trading-volume and price-volatility metrics to preserve liquidity and sector balance.
Key drivers for the ETF’s performance include Japan’s export-oriented economy, the Bank of Japan’s ultra-loose monetary stance, and sectoral weightings that heavily favor technology (e.g., semiconductor equipment), automotive manufacturers, and consumer discretionary firms. As of the most recent quarter, the Nikkei 225’s price-to-earnings ratio sits around 16×-below its 10-year average-while the yen’s 0.5 % depreciation against the dollar this year has boosted overseas earnings for many constituents.
Investors should note that the ETF’s tracking error is typically under 0.2 % due to its full-replication approach, but currency risk remains a material factor given the fund’s base currency is euros while underlying assets are priced in yen. For a deeper, data-driven analysis of how these macro- and sector-specific variables may affect future returns, consider exploring the analytical tools on ValueRay.
XDJP ETF Overview
| Market Cap in USD | 298,243m |
| Category | Japan Large-Cap Blend Equity |
| TER | 0.10% |
| IPO / Inception | 2013-01-25 |
XDJP ETF Ratings
| Growth Rating | 62.1% |
| Fundamental | - |
| Dividend Rating | 33.6% |
| Return 12m vs S&P 500 | 5.05% |
| Analyst Rating | - |
XDJP Dividends
| Dividend Yield 12m | 1.33% |
| Yield on Cost 5y | 1.98% |
| Annual Growth 5y | 7.59% |
| Payout Consistency | 85.5% |
| Payout Ratio | % |
XDJP Growth Ratios
| Growth Correlation 3m | 93.7% |
| Growth Correlation 12m | 40.2% |
| Growth Correlation 5y | 61.4% |
| CAGR 5y | 14.82% |
| CAGR/Max DD 3y (Calmar Ratio) | 0.73 |
| CAGR/Mean DD 3y (Pain Ratio) | 3.23 |
| Sharpe Ratio 12m | -0.45 |
| Alpha | 2.69 |
| Beta | 0.000 |
| Volatility | 19.68% |
| Current Volume | 91k |
| Average Volume 20d | 54.1k |
| Stop Loss | 28.1 (-3.2%) |
| Signal | 0.37 |
What is the price of XDJP shares?
Over the past week, the price has changed by -4.72%, over one month by +3.36%, over three months by +17.78% and over the past year by +19.78%.
Is Xtrackers Nikkei 225 1D a good stock to buy?
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of XDJP is around 28.55 EUR . This means that XDJP is currently overvalued and has a potential downside of -1.69%.
Is XDJP a buy, sell or hold?
What are the forecasts/targets for the XDJP price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |
| ValueRay Target Price | 32.1 | 10.4% |
XDJP Fundamental Data Overview January 01, 1970
Market Cap EUR = 259.18b (259.18b EUR * 1.0 EUR.EUR)
Beta = 0.0
Revenue TTM = 0.0 EUR
EBIT TTM = 0.0 EUR
EBITDA TTM = 0.0 EUR
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = unknown
Net Debt = unknown
Enterprise Value = 259.18b EUR (259.18b + (null Debt) - (null CCE))
Interest Coverage Ratio = unknown (Ebit TTM 0.0 / Interest Expense TTM 0.0)
FCF Yield = 0.0% (FCF TTM 0.0 / Enterprise Value 259.18b)
FCF Margin = unknown (Revenue TTM is 0 or missing)
Net Margin = unknown
Gross Margin = unknown ((Revenue TTM 0.0 - Cost of Revenue TTM 0.0) / Revenue TTM)
Tobins Q-Ratio = unknown (Enterprise Value 259.18b / Total Assets none)
Interest Expense / Debt = unknown (Interest Expense 0.0 / Debt none)
Taxrate = 25.0% (EU avg default 25%)
NOPAT = 0.0 (EBIT 0.0 * (1 - 25.00%))
Current Ratio = unknown (Total Current Assets none / Total Current Liabilities none)
Debt / Equity = unknown (Debt none)
Debt / EBITDA = unknown (Net Debt none / EBITDA 0.0)
Debt / FCF = unknown (Net Debt none / FCF TTM 0.0)
Total Stockholder Equity = 0.0 (from calculated bookValueOfEquity)
RoA = unknown (Net Income 0.0 / Total Assets none)
RoE = unknown (Net Income TTM 0.0 / Total Stockholder Equity 0.0)
RoCE = unknown (EBIT 0.0 / Capital Employed )
RoIC = unknown (NOPAT 0.0, Invested Capital 0.0, EBIT 0.0)
WACC = 9.29% (E(259.18b)/V(259.18b) * Re(9.29%) + (debt-free company))
Discount Rate = 9.29% (= CAPM, Blume Beta Adj.)
Fair Price DCF = unknown (Cash Flow 0.0)